HIT (Health In Tech, Inc. Class A Common Stock) Stock Analysis - Analyst Ratings

Health In Tech, Inc. Class A Common Stock (HIT) is a publicly traded Technology sector company. As of May 21, 2026, HIT trades at $0.97 with a market cap of $68.81M and a P/E ratio of -50.95. HIT moved +2.97% today. Year to date, HIT is -40.24%; over the trailing twelve months it is +54.22%. Its 52-week range spans $0.51 to $7.59. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces HIT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate HIT?

2 analysts cover HIT: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $4.00.

HIT Key Metrics

Key financial metrics for HIT
MetricValue
Price$0.97
Market Cap$68.81M
P/E Ratio-50.95
EPS$-0.02
Dividend Yield0.38%
52-Week High$7.59
52-Week Low$0.51
Volume241
Avg Volume0
Revenue (TTM)$34.08M
Net Income$-808.03K
Gross Margin58.95%

HIT Analyst Consensus

2 analysts cover HIT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.

Latest HIT News

Common questions about HIT

What do analysts rate HIT?
2 analysts cover HIT: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $4.00.
Does Rallies show HIT price targets?
Yes. Rallies tracks HIT analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is HIT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HIT. It does not provide personalized investment advice.
HIT

HIT